Beta Bionics, Inc.
NASDAQ:BBNX · NASDAQ Global Market
+$0.42 today
Vol 1.23M · Avg 0.99M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-12.15%
Period High
$31.99
Period Low
$8.86
Latest
$13.88
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Terns Pharmaceuticals, Inc.
TERN
$4.77B
Dynavax Technologies Corporation
DVAX
$1.82B
Pulse Biosciences, Inc.
NASDAQ:PLSE
$1.81B
STAAR Surgical Company
NASDAQ:STAA
$1.43B
Precigen, Inc.
NASDAQ:PGEN
$1.41B
AdaptHealth Corp.
NASDAQ:AHCO
$1.32B
Immatics N.V.
NASDAQ:IMTX
$1.31B
Tourmaline Bio, Inc.
TRML
$1.23B
Kestra Medical Technologies, Ltd.
NASDAQ:KMTS
$1.11B
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
$890.25M
What is the latest BBNX filing?
The latest filing shown is 4 dated Jun 5, 2026.
How many recent filings does BBNX have?
Intrinsic Alpha currently shows 20 recent filings for BBNX.
Explore More
Continue the stock analysis
Jump to another research area for this company.